These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11959538)

  • 1. New breast cancer drugs expand treatment options.
    Harv Womens Health Watch; 2002 Apr; 9(8):7. PubMed ID: 11959538
    [No Abstract]   [Full Text] [Related]  

  • 2. Deep time: the long and the short of adjuvant endocrine therapy for breast cancer.
    Burstein HJ; Griggs JJ
    J Clin Oncol; 2012 Mar; 30(7):684-6. PubMed ID: 22271478
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs may improve long-term outcomes after breast cancer.
    Mayo Clin Health Lett; 2004 Mar; 22(3):4. PubMed ID: 15000065
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer drug shows promise for some survivors.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Oct; 14(21):7-9. PubMed ID: 14628765
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
    Hamilton A; Volm M
    Oncology (Williston Park); 2001 Aug; 15(8):965-72; discussion 972, 977-9. PubMed ID: 11548977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term insurance for breast cancer survivors.
    Johns Hopkins Med Lett Health After 50; 2004 Apr; 16(2):3, 7. PubMed ID: 15088564
    [No Abstract]   [Full Text] [Related]  

  • 7. Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.
    Oncology (Williston Park); 2005 Mar; 19(3):277, 360. PubMed ID: 15828547
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aromatase inhibitors in the treatment of breast cancer].
    Perey L
    Rev Med Suisse Romande; 2000 Jun; 120(6):495-500. PubMed ID: 11014093
    [No Abstract]   [Full Text] [Related]  

  • 9. Letrozole in breast cancer.
    Hellman S; Hellman D
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971060
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting breast cancer with hormonal treatment options.
    Mellington TE; Fields MM
    Nurse Pract; 2008 May; 33(5):17-22; quiz 22-3. PubMed ID: 18458623
    [No Abstract]   [Full Text] [Related]  

  • 11. [Advancement in endocrine therapy for breast cancer].
    Yang MT; Lian ZQ
    Ai Zheng; 2007 Apr; 26(4):440-4. PubMed ID: 17430670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New treatment boosts outlook for breast cancer survivors.
    Mayo Clin Womens Healthsource; 2004 Mar; 8(3):3. PubMed ID: 15001847
    [No Abstract]   [Full Text] [Related]  

  • 13. Superiority of letrozole over tamoxifen in the first-line treatment of metastatic breast cancer patients with normal serum Her-2/neu levels: question of tamoxifen resistance.
    Altundag K; Altundag O
    J Clin Oncol; 2003 Dec; 21(24):4656; author reply 4657. PubMed ID: 14673060
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiestrogen treatment in postmenopausal patients with metastatic breast cancer].
    Lindberg H; Nielsen DL; Tuxen M; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3096-100. PubMed ID: 17877958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].
    Illiger HJ
    Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.
    Needleman SJ; Tobias JS
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1871-81. PubMed ID: 19046107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New strategies against breast carcinoma. To outwit the resistance tendency of tumor cells].
    Jakesz R
    MMW Fortschr Med; 2005 Mar; 147(10):8. PubMed ID: 15803774
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of ErbB-1 and ErbB-2 to select endocrine therapy for breast cancer: will it play in Peoria?
    Pritchard KI
    J Clin Oncol; 2001 Sep; 19(18):3795-7. PubMed ID: 11559715
    [No Abstract]   [Full Text] [Related]  

  • 19. Stick with tried-and-true breast cancer treatment.
    Health News; 2002 Jul; 8(7):5. PubMed ID: 12132502
    [No Abstract]   [Full Text] [Related]  

  • 20. New drugs reduce risk of death from breast cancer.
    Health News; 2004 Oct; 10(10):4. PubMed ID: 15584111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.